SVT is not a shockable rhythm in the way that term is typically used. In cardiac arrest protocols, “shockable rhythm” refers specifically to ventricular fibrillation and pulseless ventricular tachycardia, the two rhythms treated with defibrillation. SVT falls outside that category. However, SVT can be treated with a different type of electrical shock, called synchronized cardioversion, when it causes dangerous symptoms. The distinction matters, and understanding it can clear up a lot of confusion.
What “Shockable Rhythm” Actually Means
In emergency medicine, “shockable rhythm” has a precise definition. It refers to heart rhythms found during cardiac arrest that respond to defibrillation: ventricular fibrillation (where the heart quivers chaotically) and pulseless ventricular tachycardia (where the heart beats too fast to pump blood effectively). These are the only two shockable rhythms in the American Heart Association’s cardiac arrest algorithm. The patient has no pulse, and an unsynchronized electrical shock is delivered to reset the heart.
SVT doesn’t appear in the cardiac arrest algorithm at all. A person in SVT still has a pulse and a functioning heartbeat, even though their heart rate is abnormally fast. That’s a fundamentally different clinical situation from cardiac arrest, which is why SVT is managed under a completely separate protocol: the tachycardia-with-a-pulse algorithm.
SVT Can Still Receive an Electrical Shock
Here’s where the nuance comes in. SVT isn’t treated with defibrillation, but it can be treated with synchronized cardioversion. Both procedures send an electrical current through the chest, but they work differently. Defibrillation delivers a high-energy shock at any point in the heart’s electrical cycle, essentially hitting a hard reset. Synchronized cardioversion delivers a lower-energy shock timed to a specific moment in the heartbeat, which reduces the risk of accidentally triggering a worse rhythm.
Synchronized cardioversion is reserved for patients who still have a pulse but are hemodynamically unstable, meaning their body can’t maintain adequate blood flow despite the heart still beating. It works for both supraventricular and ventricular rhythms that are causing dangerous symptoms.
When SVT Requires Cardioversion
Most SVT episodes don’t need an electrical shock. The first-line approaches include physical maneuvers like bearing down (vagal maneuvers) and medications. But when SVT makes a patient critically unstable, synchronized cardioversion becomes necessary. The AHA identifies five warning signs that trigger this escalation:
- Hypotension: dangerously low blood pressure
- Altered mental status: confusion, disorientation, or loss of consciousness
- Signs of shock: pale skin, rapid breathing, weak pulse
- Chest pain: suggesting the heart muscle isn’t getting enough oxygen
- Acute heart failure: fluid backing up into the lungs
If any of these are present and the fast heart rate is the cause, the protocol calls for immediate synchronized cardioversion rather than waiting for medications to work.
Adenosine vs. Cardioversion for SVT
For stable SVT, adenosine (a medication given through an IV that briefly interrupts the heart’s electrical circuit) is the standard treatment. A large multicenter study of 1,234 SVT events found that 93% of patients who received prehospital treatment got adenosine, while only about 7% underwent electrical cardioversion. Adenosine successfully converted the rhythm in 80.1% of cases, compared to 83.9% for electrical cardioversion.
Interestingly, even in unstable patients, the study found that trying adenosine first may be a reasonable strategy before moving to cardioversion. Electrical cardioversion was about 2.4 times more likely to succeed in unstable patients, but adenosine still worked often enough that researchers concluded it could serve as a safe initial attempt, potentially sparing patients the need for sedation that cardioversion requires.
How Cardioversion Differs for Children
Pediatric SVT follows the same general logic, but the energy levels are weight-based rather than fixed. The AHA’s pediatric algorithm recommends starting synchronized cardioversion at 0.5 to 1 joule per kilogram of body weight. If that doesn’t work, the dose increases to 2 joules per kilogram. For adults, the energy settings are higher and depend on the type of device being used, but the principle is the same: start low and increase if needed.
Why the Distinction Matters
Confusing defibrillation with synchronized cardioversion isn’t just a terminology issue. Using an unsynchronized shock on someone in SVT could push them into ventricular fibrillation, turning a treatable fast rhythm into cardiac arrest. The synchronization feature ensures the shock lands during a safe window of the heartbeat. This is why automated external defibrillators (AEDs) found in public places are designed for cardiac arrest, not for someone experiencing SVT with a pulse.
So if you’re studying for a certification exam or trying to understand your own diagnosis: SVT is not a shockable rhythm in the cardiac arrest sense. It can receive a synchronized electrical shock when it causes hemodynamic instability, but that’s a different procedure with different equipment settings, different energy levels, and a different clinical context entirely.